Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors

被引：0
|
作者：
Robert S. Benjamin
Patrick Schöffski
Jörg Thomas Hartmann
Allan Van Oosterom
Binh Nguyen Bui
Justus Duyster
Scott Schuetze
Jean-Yves Blay
Peter Reichardt
Lee S. Rosen
Keith Skubitz
Sheryl McCoy
Yu-Nien Sun
Daniel E. Stepan
Laurence Baker
机构：
[1] University of Texas M.D. Anderson Cancer Center,Department of Sarcoma Medical Oncology
[2] University Hospital Gasthuisberg,undefined
[3] Christian-Albrechts-Universität,undefined
[4] Comprehensive Cancer Center North,undefined
[5] Institut Bergonié,undefined
[6] Technische Universität München,undefined
[7] University of Michigan Comprehensive Cancer Center,undefined
[8] Université Claude Bernard and INSERM U590 Centre L. Berard and UJOMM Pavillon E,undefined
[9] Hospital Ed. Herriot,undefined
[10] HELIOS Klinikum,undefined
[11] Premiere Oncology,undefined
[12] University of Minnesota,undefined
[13] Amgen Inc.,undefined
[14] Amgen Inc.,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Angiogenesis; GIST; Imatinib; Kit receptor; Motesanib; VEGF receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：69 / 77
页数：8
相关论文
共 50 条
  • [1] Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors
    Benjamin, Robert S.
    Schoffski, Patrick
    Hartmann, Joerg Thomas
    Van Oosterom, Allan
    Binh Nguyen Bui
    Duyster, Justus
    Schuetze, Scott
    Blay, Jean-Yves
    Reichardt, Peter
    Rosen, Lee S.
    Skubitz, Keith
    McCoy, Sheryl
    Sun, Yu-Nien
    Stepan, Daniel E.
    Baker, Laurence
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 69 - 77
  • [2] Efficacy of Sunitinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors
    Cubukcu, Sinem
    Kanat, Ozkan
    Cubukcu, Erdem
    Olmez, Omer Fatih
    Canhoroz, Mustafa
    Avci, Nilufer
    Hartavi, Mustafa
    Deligonul, Adem
    Seyhan, Serdar
    Ayyildiz, Aylin
    Tasdemir, Unal
    Manavoglu, Osman
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2014, 5 (04)
  • [3] Efficacy and safety of sunitinib in Chinese patients with imatinib-resistant or -intolerant gastrointestinal stromal tumors
    Li, Jian
    Gao, Jing
    Hong, Jinlin
    Shen, Lin
    FUTURE ONCOLOGY, 2012, 8 (05) : 617 - 624
  • [4] Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors
    Chen, Weicai
    Kuang, Ye
    Qiu, Hai-Bo
    Cao, Zhifa
    Tu, Yuqing
    Sheng, Qing
    Eilers, Grant
    He, Quan
    Li, Hai-Long
    Zhu, Meijun
    Wang, Yuexiang
    Zhang, Rongqing
    Wu, Yeqing
    Meng, Fanguo
    Fletcher, Jonathan A.
    Ou, Wen-Bin
    CANCER RESEARCH, 2017, 77 (18) : 5107 - 5117
  • [5] Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors
    Yuan-Shuo Hsueh
    Hui Hua Chang
    Yan-Shen Shan
    H. Sunny Sun
    Jonathan Alfred Fletcher
    Chien-Feng Li
    Li-Tzong Chen
    Oncogene, 2019, 38 : 6550 - 6565
  • [6] Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors
    Hsueh, Yuan-Shuo
    Chang, Hui Hua
    Shan, Yan-Shen
    Sun, H. Sunny
    Fletcher, Jonathan Alfred
    Li, Chien-Feng
    Chen, Li-Tzong
    ONCOGENE, 2019, 38 (38) : 6550 - 6565
  • [7] Ripretinib for the treatment of advanced, imatinib-resistant gastrointestinal stromal tumors
    Liu, Wei Zhen
    Du, Yu Qiang
    Shen, Qian
    Tao, Kai Xiong
    Zhang, Peng
    JOURNAL OF DIGESTIVE DISEASES, 2023,
  • [8] Identification of Novel Imatinib-Resistant Genes in Gastrointestinal Stromal Tumors
    Cao, Lei
    Zheng, Kunming
    Liu, Yanhong
    Song, Peng
    Wang, Chuntao
    Wang, Hongzhi
    Wang, Nan
    Zhang, Shiwu
    Zhao, Yongjie
    FRONTIERS IN GENETICS, 2022, 13
  • [9] Current clinical strategy for imatinib-resistant gastrointestinal stromal tumors
    Yamamoto M.
    Konno H.
    Clinical Journal of Gastroenterology, 2009, 2 (3) : 137 - 142
  • [10] Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors
    Serrano, Cesar
    George, Suzanne
    Valverde, Claudia
    Olivares, David
    Garcia-Valverde, Alfonso
    Suarez, Cristina
    Morales-Barrera, Rafael
    Carles, Joan
    TARGETED ONCOLOGY, 2017, 12 (03) : 277 - 288
12345